Dr Subhendu Basu
COO
Adaptive Phage Therapeutics
Dr Milana Boukhman Trounce
Director of Biosecurity & Pandemic Resilience & Response, Clinical Professor of Emergency Medicine
Stanford University
Dr Barbara Hubad
COO
JAFRAL, Ltd
Dr Bob Blasdel
Research Director
Vesale Pharma
Dr Danielle van Dalen
Senior Advisor
PA Europe
Dr Graham Hatfull
Eberly Family Professor of Biotechnology
University of Pittsburgh
Professor Martha Clokie
Professor of Microbiology
University of Leicester
Martha Clokie is Professor of Microbiology at the University of Leicester where she leads a group of post-doctoral researchers and PhD students working on different aspects of therapeutic development of phages that target human and animal pathogens. Her work encompasses all aspects of phage therapy development – from unravelling fundamental biology to product development, and commercialisation. She is currently developing phages for major gut pathogens including Clostridial and Salmonella species, for respiratory pathogens and for antibiotic resistant bacteria that cause UTIs. She is also developing a phage based diagnostic test for Borrelia. Three patents have been filed from her work.
Dr Sailaja Puttagunta
CMO
BiomX
